Study in Patients With Advanced Solid Malignancies to Evaluate the Safety of FTL001
Abroad (travel likely)RecruitingPHASE1
Conditions
Solid Tumor
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Cancer Institute and Hospital, Chinese Academy of Medical Sciences, Beijing, Beijing Municipality, China
Contact: Study coordinator (Yuankai Shi, MD)Chongqing University Cancer Hospital, Chongqing, Chongqing Municipality, China
Contact: Study coordinator (Yongsheng Li, MD)West China Hospital, Chengdu, Sichuan, China
Contact: Study coordinator (Li Zheng, MD)Contact: Study coordinator (Yongsheng Wang, MD)
Study leads
Yuankai Shi, MD
Principal Investigator
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Shoubin Wen, MD
Study Director
Sound Biopharmaceuticals Ltd.